Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis

Molecular Carcinogenesis

Volumn 17, Issue 3, 1996, Pages 134-143

  Haag, Jill D ^a   Hsu, Lih Ching ^a,c   Newton, Michael A ^b   Gould, Michael N ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Loss of heterozygosity; Mutation; Ras

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CARCINOGENESIS; CANCER SUSCEPTIBILITY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; IONIZING RADIATION; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ALLELES; ANIMALS; CARCINOGENS; CHROMOSOMES; DISEASE SUSCEPTIBILITY; DNA, NEOPLASM; FEMALE; GENE DELETION; GENES, RAS; GENES, TUMOR SUPPRESSOR; GENOME; HETEROZYGOTE; MAMMARY NEOPLASMS, EXPERIMENTAL; MUTATION; NEOPLASMS, RADIATION-INDUCED; PHENOTYPE; RATS; RATS, INBRED F344; RATS, INBRED WKY; SPECIES SPECIFICITY;

ANIMALIA;

EID: 0029952874     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199611)17:3<134::AID-MC5>3.0.CO;2-F     Document Type: Conference Paper

References (33)

1. Castilla LH, Couch FJ, Erdos MR, et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer. Nat Genet 8:387-391, 1994.
2. Friedman LS, Ostermeyer EA, Szabo CI, et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8:399-404, 1994.
3. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2, Nature 378:789-792, 1995.
4. Sukumar S, McKenzie K, Chen Y. Animal models for breast cancer. Mutat Res 333:37-44, 1995.
5. Isaacs JT. Genetic control of resistance to chemically induced mammary adenocarcinogenesis in the rat. Cancer Res 46:3958-3963, 1986.
6. Haag JD, Newton MA, Gould MN. Mammary carcinoma suppressor and susceptibility genes in the Wistar-Kyoto rat, Carcinogenesis 13:1933-1935, 1992.
7. Gould MN. Inheritance and site of expression of genes controlling susceptibility to mammary cancer in an inbred rat model. Cancer Res 46:1199-1202, 1986.
8. Hsu LC, Kennan WS, Shepel LA, et al. Genetic identification of Mcs-1, a rat mammary carcinoma suppressor gene. Cancer Res 54:2765-2770, 1994.
9. Yamada J, Kuramoto T, Serikawa T. A rat genetic linkage map and comparative maps for mouse or human homologous rat genes. Mammalian Genome 5:63-83, 1994.
10. Brown MA, Jones KA, Nicolai H, et al. Physical mapping, cloning, and identification of genes within a 500-kb region containing Brca1. Proc Natl Acad Sci USA 92:4362-4366, 1995.
11. Fischer SG, Cayanis E, de Fatima Bonaldo M, et al. A high-resolution annotated physical map of the human chromosome 13q12-13 region containing the breast cancer susceptibility locus BRCA2. Proc Natl Acad Sci USA 93:690-694, 1996.
12. Knudson AG. Genetics of human cancer. Ann Rev Genet 20:231-251, 1986.
13. Clifton KH, Barnes JY, Tanner MA, Haning RV. Radiation and prolactin effects on rat mammary carcinogenesis: Intrasplenic pituitary and estrone capsule implants. J Natl Cancer Inst 75:167-175, 1985.
14. Chen KS, Shepel LA, Haag JD, Heil GM, Gould MM. Cloning, genetic mapping and expression studies of the rat Brca1 gene. Carcinogenesis, in press.
15. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1982, pp. 364-401.
16. Barnard GA. Discussion of paper by M.S. Bartlett Journal of the Royal Statistical Society, Series B, 25:294, 1963.
17. Jacob HJ, Brown DM, Bunker RK, et al. A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet 9:63-69, 1995.
18. Gollahon LS, Aldaz CM. Chromosomal localization of the rat Harvey-ras-1 gene (HRAS) by in situ hybridization. Cytogenet Cell Genet 61:123-124, 1992.
19. Gollahon LS, Chen A, Aldaz CM. Loss of heterozygosity at chromosome 1q loci in rat mammary tumors. Mol Carcinog 12:7-13, 1995.
20. Miyasaka K, Ohtake K, Nomura K, et al. Frequent loss of heterozygosity on chromosome 4 in diethylnitrosamine-induced C3H/MSM mouse hepatocellular carcinomas in culture. Mol Carcinog 13:37-43, 1995.
21. Wiseman RW, Cochran C, Dietrich W, Lander ES, Soderkvist P. Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: Frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc Natl Acad Sci USA 91:3759-3763, 1994.
22. Davis LM, Caspary WJ, Sakallah SA, et al. Loss of heterozygosity in spontaneous and chemically induced tumors of the B6C3F1 mouse. Carcinogenesis 15:1637-1645, 1994.
23. Manenti G, de Gregorio L, Gariboldi M, Dragain TA, Pierotti MA. Analysis of loss of heterozygosity in murine hepatocellular tumors. Mol Carcinog 13:191-200, 1995.
24. Hsu LC, Gould MN. Cloning and characterization of overexpressed genes in the mammary gland of rat strains carrying the mammary carcinoma suppressor (Mcs) gene. Cancer Res 53:5766-5774, 1993.
25. Winqvist R, Hampton GM, Mannermaa A, et al. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 55:2660-2664, 1995.
26. Radford DM, Phillips NJ, Fair KL, Ritter JH, Holt M, Donis-Keller H. Allelic loss and the progression of breast cancer. Cancer Res 55:5180-5183, 1995.
27. Hao Y, Crenshaw T, Moulton T, Newcomb E, Tycko B. Tumour-suppressor activity of H19 RNA. Nature 365:764-767, 1993.
28. Cohen MM. Wiedemann-Beckwith syndrome, imprinting, IGF2, and H19: Implications for hemihyperplasia, associated neoplasms, and overgrowth. Am J Med Genet 52:233-234, 1994.
29. Bremner R, Balmain A. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61:407- 417, 1990.
30. Yuan B, Heniford BW, Ackermann DM, Hawkins BL, Hendler FJ. Harvey ras (H-ras) point mutations are induced by 4-nitroquinoline-1-oxide in murine oral squamous epithelia, while squamous cell carcinomas and loss of heterozygosity occur without additional exposure. Cancer Res 54:5310-5317, 1994.
31. Hegi ME, Devereux TR, Dietrich WF, et al. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res 54:6257-6264, 1994.
32. Zhang R, Haag JD, Gould MM. Reduction in the frequency of activated ras oncogenes in rat mammary carcinomas with increasing N-methyl-N-nitrosourea doses or increasing prolactin levels. Cancer Res 50:4286-4290, 1990.
33. Toyota M, Ushijima T, Weisburger JH, et al. Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Mol Carcinog 15:176-182, 1996.